Is Vericel Corp. (VCEL) setting the stage for another year of growth? With profitability for the second straight year, no debt, and strategic investments fueling future expansion, the company's preliminary 2025 results highlight rising revenue, expanding MACI utilization, and plans for new manufacturing capacity as it heads into 2026.
Vericel, a company specializing in sports medicine and burn care treatments, reported preliminary total net revenue of about $276 million for 2025, with MACI contributing $239.5 million and burn care products generating $36.5 million.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com